Company Filing History:
5 out of 120 
6 out of 832,891 Years Active: 1999-2005
Title: The Innovative Contributions of Amitabh Gaur
Introduction
Amitabh Gaur is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biomedical research, particularly in the development of peptide analogues for the treatment of various diseases. With a total of 11 patents to his name, Gaur's work has the potential to impact the lives of many patients suffering from chronic conditions.
Latest Patents
Gaur's latest patents include groundbreaking methods for the treatment of diabetes using peptide analogues of insulin. This invention focuses on peptide analogues derived from the B chain of insulin, specifically altering residues at positions 12, 13, 15, and/or 16. These modifications aim to enhance the efficacy of insulin in managing diabetes. Additionally, he has developed methods for treating multiple sclerosis through peptide analogues that modify residue 91 of human myelin basic protein. These analogues are designed to provide therapeutic benefits to patients suffering from this debilitating condition.
Career Highlights
Throughout his career, Amitabh Gaur has worked with notable companies, including Neurocrine Biosciences, Inc. His experience in the industry has allowed him to translate his innovative ideas into practical applications that can benefit patients. Gaur's dedication to research and development has positioned him as a key figure in the field of biomedical innovation.
Collaborations
Amitabh Gaur has collaborated with esteemed colleagues such as Paul J Conlon and Nicholas C Ling. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Amitabh Gaur's contributions to the field of biomedical research through his innovative patents demonstrate his commitment to improving patient care. His work in developing peptide analogues for the treatment of diabetes and multiple sclerosis highlights the importance of innovation in addressing complex health challenges.